EGFR and cancer: Mechanistic studies demonstrated that high CYP2J2 expression strongly enhanced proliferation and reduced apoptosis in several cancers via the activation of kinase/Akt signaling pathways and increased the phosphorylation of epidermal growth factor receptor (EGFR).